Skip to main content

14-11-2019 | Juvenile idiopathic arthritis | Video | Article

Expert commentary: Safety and efficacy of tofacitinib in juvenile idiopathic arthritis

Sangeeta Sule gives a pediatric rheumatologist’s view on a trial looking at tofacitinib for the treatment of polyarticular juvenile idiopathic arthritis and the potential implementation of the results in the clinic (2:55).


Back to the ACR/ARP 2019 conference hub

New additions to the Adis Journal Club

A selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

Image Credits